genentech headquarters roche francisco san south its aggressive doubling includes plans completes purchase drug technology biotech calif swiss pharmaceutical agreed
neoantigens neoantigen directed specific adaptive immunity genentech therapies possibility sullivan essential gene
infectious disease diseases antimicrobials resistance serious growing treatment problem
cancer immunity cycle immunotherapy tumor advances developed behind gif gene genentech